SATLARS T8 Total Laboratory Automation System
SATLARS T8 stands as Snibe’s independently developed total laboratory automation (TLA) solution, representing the company’s most integrated diagnostic workflow system. The 18-meter modular platform connects pre-analytical processing, multi-disciplinary analyzers, and post-analytical handling into a unified automated workflow for high-volume clinical laboratories.
Product Overview
Developed entirely by Snibe without reliance on external automation partners, the SATLARS T8 embodies the company’s vision for fully automated clinical laboratory operations. The system eliminates manual sample handling throughout the testing process, from initial specimen receipt through result delivery and sample archiving.
The platform’s modular architecture allows laboratories to configure systems matching their specific testing volumes and discipline requirements. A single SATLARS T8 installation can simultaneously process samples for immunoassay, biochemistry, molecular diagnostics, and coagulation testing, with intelligent sample routing ensuring optimal analyzer utilization.
Key Features
SATLARS T8’s 18-meter modular architecture links immunoassay, biochemistry, molecular, and coagulation analyzers into a single automated pipeline for high-volume laboratories.
Modular Matrix Design: The system comprises four primary component categories—pre-analytical modules, analytical modules, post-analytical modules, and conveyor systems—that can be combined in various configurations to match laboratory space constraints and workflow requirements.
Pre-Analytical Automation: Integrated modules handle sample input/output, centrifugation, tube decapping, aliquoting, and barcode verification. Automated sorting and routing direct specimens to appropriate analyzers based on test orders.
Multi-Disciplinary Integration: The analytical section accommodates Snibe’s full instrument portfolio including MAGLUMI X8 immunoassay analyzers (600 T/H), Biossays C8 biochemistry analyzers (1,600 T/H), Molecision R8 molecular platforms (448 T/8H), and Hemolumi H6 coagulation systems.
Intelligent Sample Management: Software algorithms optimize sample flow, minimize turnaround time, and provide real-time tracking visibility. The system supports priority sample processing and stat specimen handling without disrupting routine workflow.
Post-Analytical Processing: Automated recapping, sorting, and archival storage modules complete the workflow, preparing samples for potential reflex testing or regulatory retention requirements.
Technical Specifications
Deployed in China and CE-marked for Europe, SATLARS T8 connects pre-analytical, multi-disciplinary, and post-analytical modules across a configurable 18-meter track.
| Parameter | Specification |
|---|---|
| System Length | 18 meters (configurable) |
| Design | Modular matrix architecture |
| Sample Input Capacity | Continuous loading |
| Pre-Analytical Functions | Centrifugation, decapping, aliquoting, sorting |
| Compatible Analyzers | MAGLUMI, Biossays, Molecision, Hemolumi series |
| Immunoassay Throughput | Up to 600 T/H (MAGLUMI X8) |
| Biochemistry Throughput | Up to 1,600 T/H (Biossays C8) |
| Molecular Throughput | 448 T/8H (Molecision R8) |
| Post-Analytical Functions | Recapping, sorting, archival storage |
| Software | iXLAB intelligent laboratory management |
Clinical Applications
The SATLARS T8 serves high-volume clinical laboratory environments requiring automated multi-disciplinary testing:
Hospital Central Laboratories: Large tertiary hospitals processing thousands of samples daily benefit from reduced manual handling, consistent turnaround times, and consolidated workflow management.
Independent Clinical Laboratories: Commercial laboratory chains use the system’s scalability and efficiency for cost-effective high-volume operations.
Regional Reference Laboratories: Facilities serving multiple healthcare institutions use SATLARS T8’s full testing capabilities and standardized processing.
Integrated Diagnostic Workflows: The platform enables simultaneous immunoassay, biochemistry, molecular, and coagulation testing from single sample tubes, minimizing blood draw volumes and accelerating multi-test diagnostic panels.
Regulatory Status
| Region | Status | Date |
|---|---|---|
| China (NMPA) | Approved | Yes |
| European Union (CE) | Certified | Yes |
| United States (FDA) | Not Cleared | - |
The SATLARS T8 system carries NMPA registration for the Chinese market and CE marking for European distribution, supporting installation in laboratories across multiple continents.
Frequently Asked Questions
What analyzers are compatible with SATLARS T8?
The SATLARS T8 integrates with Snibe’s complete diagnostic instrument portfolio: MAGLUMI X series chemiluminescence immunoassay analyzers, Biossays biochemistry analyzers, Molecision molecular diagnostics platforms, and Hemolumi coagulation systems. This enables full multi-disciplinary testing within a unified automated workflow.
How does SATLARS T8 compare to other laboratory automation systems?
The SATLARS T8 competes with TLA solutions from established laboratory automation providers including Roche (cobas connection modules), Siemens (Aptio Automation), Abbott (GLP Systems), and Beckman Coulter (DxA 5000). Snibe positions SATLARS T8 as an independently developed Chinese alternative with competitive pricing, full compatibility with domestic analyzers, and thorough local service support.
What laboratory size is appropriate for SATLARS T8?
The SATLARS T8’s modular design accommodates laboratories of varying scales, though the system is optimized for medium to large facilities processing several thousand samples daily. Smaller configurations suit regional hospital laboratories, while full-scale installations address the needs of major reference laboratories and hospital networks.
Browse related categories
Sources
Publicly available references used for the data on this page. See data methodology for verification standards.